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Abstract
Background:  The Wnt/beta-catenin signaling pathway plays an important role in skeletal
development. Polymorphisms of frizzled-related protein (FRZB), an antagonist of this pathway, may
generate variations in bone mineral density (BMD). In this study, we analyzed the association
between FRZB genotypes and peak BMD variation in the spines and hips of two relatively large
samples of Chinese female-offspring and male-offspring nuclear families.
Methods: We recruited 1,260 subjects from 401 female-offspring nuclear families and 1,296
subjects from 427 male-offspring nuclear families and genotyped four tagging single nucleotide
polymorphisms (tagSNPs) (rs6433993, rs409238, rs288324, and rs4666865) spanning the entire
FRZB gene. The SNPs rs288326 and rs7775, which are associated with hip osteoarthritis, were not
selected in this study because of their low minor allele frequencies (MAFs) in Chinese people. The
quantitative transmission disequilibrium test (QTDT) was used to analyze the association between
each SNP and haplotype with peak BMD in female- and male-offspring nuclear families.
Results: In the female-offspring nuclear families, we found no evidence of an association between
either single SNPs or haplotypes and peak BMD in the spine or hip. In the male-offspring nuclear
families, no within-family association was observed for either SNPs or haplotypes, although a
significant total association was found between rs4666865 and spine BMD (P = 0.0299).
Conclusion: Our results suggest that natural variation in FRZB is not a major contributor to the
observed variability in peak BMD in either Chinese females or males. Because ethnic differences in
the FRZB genotypes may exist, other studies in different population are required to confirm such
results.
Background
Osteoporosis is a skeletal disorder characterized by fragile
bones susceptible to low trauma fractures. One of the
most important determinants for osteoporotic fracture is
low bone mineral density (BMD) [1,2], which is under
strong genetic control, with heritability estimates ranging
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from 50% to 80% [3-5]. Osteoporosis is associated with
peak bone mass achieved during early adulthood and the
rate of bone loss later in life. Identification of genes under-
lying peak BMD may be useful in predicting the risk of
low bone mass and osteoporosis in later life.
The Wnt/beta-catenin signaling pathway plays an impor-
tant role in skeletal development and growth [6,7]. In this
pathway, Wnt signaling is transmitted to the nucleus
when Wnt binds to the frizzled receptor/low-density lipo-
protein receptor-related protein (LRP) 5 or 6 coreceptor
complex. Variations in LRP5 and frizzled genes are associ-
ated with bone mass variation [8-12]. The signaling func-
tion of the Wnt/beta-catenin signaling pathway is
antagonized by secreted frizzled related proteins (sFRPs).
One member of the sFRP family is the frizzled-related pro-
tein gene (FRZB), which is mapped to human chromo-
some 2q31-33 and consists of 6 exons and 5 introns [13].
FRZB (also called secreted frizzled-related protein 3,
sFRP3), which contains a cysteine-rich domain that is
highly homologous to the ligand-binding domain of friz-
zled receptors [14], antagonizes Wnt signaling by binding
to Wnt ligands in the extracellular space and sequestering
them from their frizzled receptors [15]. Many studies have
reported that sFRP3 might play a role in skeletal morpho-
genesis [16] and protect against the development of carti-
lage damage in human disease and in mouse models [17-
21]. Frzb-knockout mice, although phenotypically normal
at birth, experience an accelerated loss of cartilage integ-
rity [18] and have increased cortical bone thickness and
density [22]. Loughlin et al. [17] found that Arg324Gly
substitution within the FRZB gene was associated with hip
osteoarthritis, and that a haplotype coding for Arg200Trp
and Arg324Gly substitutions in FRZB was a strong risk
factor for primary hip osteoarthritis in females. However,
before now, the relationship between FRZB gene poly-
morphisms and BMD variation has never been published.
In this study, we analyzed the association of four tagging
single nucleotide polymorphisms (tagSNPs) and the hap-
lotypes defined in the FRZB gene with peak BMD varia-
tion in the spines and hips of two relatively large samples
of Chinese female-offspring nuclear families and male-
offspring nuclear families. The two SNPs rs288326
(Arg200Trp) and rs7775 (Arg324Gly) analyzed by Lough-
lin et al. [17] were not selected in this study because of
their low minor allele frequencies (MAFs) of 0 and 0.011,
respectively, in the Chinese population.
Methods
Subjects
The study was approved by the Ethics Committee of
Shanghai Jiao Tong University Affiliated Sixth People's
Hospital. All of subjects involved in this study were
recruited by the Department of Osteoporosis from the
local population of Shanghai City and signed informed
consent documents before entering the study. We
recruited 401 female-offspring nuclear families, com-
posed of both parents and at least one healthy daughter,
totaling of 1,260 individuals, and 427 male-offspring
nuclear families, composed of both parents and at least
one healthy son, totaling 1,296 individuals. All of the
nuclear families have lived in Shanghai for at least three
generations and were recruited using public advertising
from universities and social and community centers from
2001 to 2007. All of the participants belong to the Chi-
nese Han ethnic group, identified by a combination of
self-reporting and identification cards. The average size of
the investigated female-offspring nuclear families was
3.14 people, in which 348, 50, 2, and 1 families had one,
two, three, and four daughters, respectively [23,24]. In the
investigated male-offspring nuclear families, the average
family size was 3.03, in which 412 and 15 families had
one and two sons, respectively. All of the recruited daugh-
ters and sons were 18-44 years old and healthy, and the
daughters were premenopausal. For each participant, we
also collected information on age, sex, medical history,
family history, physical activity, dietary habits, smoking
history, and other lifestyle variables. The exclusion criteria
for daughters have been detailed elsewhere [23,24]. The
following exclusion criteria were used for sons to mini-
mize any known potential confounding effects on the
studied phenotypes: (1) serious residuals from cerebral
vascular disease; (2) diabetes mellitus; (3) chronic renal
disease; (4) serious chronic liver disease or alcoholism;
(5) significant chronic lung disease; (6) corticosteroid
therapy at pharmacologic levels for >6 months; (7) treat-
ment with anticonvulsant therapy for >6 months; (8) evi-
dence of other metabolic or inherited bone diseases, such
as hyper- or hypoparathyroidism, Paget's disease of bone,
osteomalacia, osteogenesis imperfecta, or others; (9)
rheumatoid arthritis or collagen disease; (10) recent
major gastrointestinal disease (within the past year), such
as peptic ulcer, malabsorption, chronic ulcerative colitis,
regional enteritis, or any significant chronic diarrhea state;
(11) significant disease of any endocrine organ that would
affect bone mass; (12) hyperthyroidism; and (13) any
neurological or musculoskeletal condition that would be
a non-genetic cause of low bone mass.
BMD measurements
BMD (g/cm2) of the lumbar spine (L1-L4) and left proxi-
mal femur including the total hip and femoral neck, was
measured by dual-energy X-ray absorptiometry (DXA) on
a Hologic QDR 2000 (Hologic, Bedford, MA, USA) for
female-offspring families and on a Lunar Prodigy (GE
Lunar Corp., Madison WI, USA) for male-offspring fami-
lies. Both of the scanners were calibrated daily, and the
coefficient of variability (CV) values of the DXA measure-
ments at L1-4, total hip, and femoral neck were 0.9%,
0.8%, and 1.93%, respectively, for the Hologic QDR 2000BMC Medical Genetics 2010, 11:1 http://www.biomedcentral.com/1471-2350/11/1
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[23,24] and 1.39%, 0.7%, and 2.22%, respectively, for the
Lunar Prodigy [25]. The long-term reproducibility of the
DXA data during the trial, based on weekly repeated phan-
tom measurements, was 0.45%. Weight and height were
measured using a calibrated balance beam scale and a cal-
ibrated stadiometer, respectively.
SNP selection and genotyping
SNPs located within the FRZB gene were selected from
NCBI's LocusLink http://www.ncbi.nlm.nih.gov/
LocusLink/ and HapMap http://hap
map.ncbi.nlm.nih.gov/. Polymorphisms spanning the
FRZB gene were selected from the SNPs resource based on
the estimated pairwise linkage disequilibrium (LD), r2,
between all common SNPs. The tagging SNPs were
selected from each bin such that they constituted a mini-
mal set of highly informative markers while minimizing
redundant data. SNPs in FRZB gene were evaluated for the
following criteria: (1) validation status, especially in Chi-
nese; (2) degree of heterozygosity (MAFs > 10%); (3) r2 =
0.8; and (4) being tagSNPs. Using these criteria, we
selected four tagSNPs (rs6433993, rs409238, rs288324,
and rs4666865), which are located in intron 1, intron 2,
intron 5, and 3' near gene, respectively.
Genomic DNA was extracted using a standard phenol-
chloroform extraction procedure. DNA concentration was
assessed by UV-VIS spectrophotometry (Uvmini-1240).
SNPs rs409238, rs288324, and rs4666865 were geno-
typed using the TaqMan assay, with the primer and probe
sequences optimized using the SNP assay-by-design serv-
ice of Applied Biosystems. One allelic probe was labeled
with FAM dye and the other with fluorescent VIC dye. The
genotype for every sample was named according to the
ratio of the fluorescence intensities of the two dyes. The
sequences of the PCR primers for the three SNPs are pre-
sented in Table 1. Reactions were performed in a
Mx3000P Real-Time PCR System (STRATAGENE, CA)
with 20 ng genomic DNA in a 10-μl reaction volume in
every well. It was not possible to genotype rs6433993 by
TaqMan, so it was genotyped by polymerase chain reac-
tion and restriction fragment length polymorphism (PCR-
RFLP). The primers for genotyping this polymorphism are
summarized in Table 1. Genomic DNA (0.1-0.3 μg) was
amplified in a 10-μl final reaction mixture. After amplifi-
cation, the PCR product was digested with restriction
endonuclease Eco 47I (Ava) and electrophoresed in 2.5%
agarose. The presence and absence of the restriction
enzyme site were defined as G (60 bp+112 bp) and A (172
bp), respectively.
Statistical analysis
Regular statistical analyses were performed using SPSS
version 11.0 (SPSS, Chicago, IL, USA). Allele frequencies
for each SNP were calculated by allele counting, and the
Hardy-Weinberg equilibrium (HWE) was assessed by χ2
analysis. The heritability estimates were conducted using
the linear regression of parents' mean value and off-
spring's value of every phenotype (described at http://
www.heritability.com). Statistical power was estimated by
the Piface program (version 1.65 http://
www.math.uiowa.edu/~rlenth/Power/) in our current
sample size according to the MAF of every genotype and
the variation in BMD. Linkage disequilibrium block struc-
ture was examined using the Haploview verision 3.2 [26]
in unrelated parents. Haplotypes were constructed from
the population genotype data by the algorithm of
Stephens using Phase software version 2.0.2 [27].
The quantitative transmission disequilibrium test (QTDT)
program (available at http://www.sph.umich.edu/csg/
abecasis/QTDT/), a powerful family-based test for nuclear
families of any size, was used to test for population strati-
fication, total association, within-family association, and
linkage between each SNP and haplotypes with BMD phe-
notypes. Total association is sensitive to population strat-
ification, and with-family association is unaffected by
population stratification and significant only when link-
age disequilibrium is present. Because there was the pos-
sibility of generating false-positive results in the present
study, to assess the reliability of the results, permutations
(1000 simulations) were performed to generate the
Table 1: Information and the primer and probe sequences for the studied SNPs in the FRZB gene
dbSNP Polymorphism Domain primer sequence 5'-3' TaqMan probe sequence
rs6433993 A/G intron 1 F: CTGCTGAAATTAACATACCTGACCTGGATTT
AAATATATACCAGTTCAGTGTGATAGGTC
R: CAAAATTTGTAAATGATAAGCATCCTA
rs409238 A/G intron 2 F: TCTGGAGCACCTTTGGAACAG
R: GGGAACATTAGTGTAAGTCAGATGCT
VIC-CGCCAAGAACAGGTT
FAM-CGCCAAGAGCAGGTT
rs288324 A/G intron 5 F: CTTGAAATGCATCTCCCTTTTGACA
R: GTAAGGAGAAACTACCCTCCAGTAAGT
VIC-TCTTCTCCCCTTTAGTAGAT
FAM-TCTCCCCTTCAGTAGAT
rs4666865 A/G 3'near gene F: TGGTTCTACTAATAGCACACATGTAAATGG
R: CTTAGAGCCTGTGCCAATTACTTG
VIC-CAGAGAATGAAACTTT
FAM-CAGAGAATGAGACTTT
The rs6433993 was genotyped by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) and did not use a TaqMan 
probeBMC Medical Genetics 2010, 11:1 http://www.biomedcentral.com/1471-2350/11/1
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empirical p values [24,28,29]. Linkage tests are based on
the identity-by-descent (IBD) relationships of genotypes
among family members.
In all of the statistical analyses, raw BMD values were
adjusted by age, height, and weight as covariates. Sex was
not used as a covariate because male- and female-off-
spring nuclear families were tested separately, and the par-
ents' phenotypes were excluded in the QTDT. By
performing the Shapiro-Wilks test, we found the BMD
data in our sample generally did not deviate significantly
from the normal distribution. In all analyses, P < 0.05 was
considered significant.
Results
Basic characteristics of the subjects
A total of 1,260 individuals from 401 female-offspring
nuclear families, comprising 802 parents and 458 female
offspring and 1,296 individuals from 427 male-offspring
nuclear families, comprising including 854 parents and
442 male offspring were recruited. From these 427 male
offspring nuclear families, samples from 15 individuals
could not be amplified in the PCR due to the poor quality
of DNA, and 12 sons deviated from the Mendelian inher-
itance. Therefore, we had 400 male-offspring nuclear fam-
ilies for our analyses. The basic characteristics of the study
subjects are presented in Table 2. Parents in female-off-
spring nuclear families seemed to have lower BMD values
than parents in male-offspring nuclear families because of
the different DXA devices used in the two cohorts. Because
we analyzed the association between FRZB genotypes and
peak BMD variation in female-offspring nuclear families
and male-offspring nuclear families separately, and the
effects of parents' phenotypes were excluded in the QTDT,
we did not transform the BMD data. Peak BMD is thought
to be under strong genetic control. In our male samples,
the heritability estimates for peak BMD in the spine, total
hip and femoral neck were 0.565, 0.693, and 0.702,
respectively, which agreed with the heritability for peak
BMD in the female samples [30].
Table 3: Frequencies of selected FRZB polymorphism in the Chinese population
dbSNP Genotype Parents in female-offspring 
nuclear families (n = 802)
Parents in male-offspring nuclear 
families (n = 800)
All parents (n = 1602) MAF (%)
rs6433993 AA 243(0.303) 205(0.256) 448(0.280) 46.8
AG 405(0.505) 403(0.504) 808(0.504)
GG 154(0.192) 192(0.240) 346(0.216)
rs409238 AA 170(0.212) 133(0.166) 303(0.189) 44.6
AG 414(0.516) 411(0.514) 825(0.515)
GG 218(0.272) 256(0.320) 474(0.296)
rs288324 AA 169(0.211) 140(0.175) 309(0.193) 44.3
AG 392(0.489) 409(0.511) 801(0.500)
GG 241(0.300) 251(0.314) 492(0.307)
rs4666865 AA 559(0.697) 558(0.697) 1117(0.697) 16.2
AG 229(0.286) 224(0.280) 453(0.283)
GG 14(0.017) 18(0.023) 32(0.020)
MAF minor allele frequency
MAFs of each SNP are calculated from all of the parents of the nuclear families
Table 2: Basic characterstics of the study subjects
Female-offspring nuclear familiesa Male-offspring nuclear familiesb
Father Mother Daughter Father Mother Son
n 401 401 458 400 400 415
Age (years) 62.4 ± 6.6 62.4 ± 6.6 31.4 ± 5.8 61.1 ± 7.1 58.4 ± 6.3 30.4 ± 6.1
Height (cm) 165.7 ± 10.4 154.6 ± 5.6 159.8 ± 5.1 167.7 ± 6.1 155.9 ± 5.4 172.9 ± 5.9
Weight (kg) 68.3 ± 10.6 59.2 ± 8.6 55.0 ± 8.0 69.7 ± 9.5 58.3 ± 8.3 70.7 ± 10.8
Lumbar spine BMD (g/cm2) 0.930 ± 0.149 0.813 ± 0.151 0.960 ± 0.102 1.138 ± 0.171 0.994 ± 0.170 1.138 ± 0.137
Total hip BMD (g/cm2) 0.875 ± 0.123 0.749 ± 0.134 0.854 ± 0.108 0.966 ± 0.130 0.869 ± 0.149 1.015 ± 0.137
Femoral neck BMD (g/cm2) 0.750 ± 0.115 0.677 ± 0.122 0.776 ± 0.108 0.891 ± 0.132 0.797 ± 0.144 0.998 ± 0.143
All data are presented as mean ± SD for the raw phenotype values without adjustment.
a Female-offspring families were measured by DXA on a Hologic QDR 2000.
b Male-offspring families were measured by DXA on a Lunar ProdigyBMC Medical Genetics 2010, 11:1 http://www.biomedcentral.com/1471-2350/11/1
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Frequencies of alleles and haplotypes
The data of four FRZB SNPs is summarized in Table 1. All
of the four SNPs are tagSNPs, although no potential func-
tional missense was found. The SNPs were arranged in the
order of rs6433993, rs409238, rs288324, rs4666865 from
5' to 3'. The MAFs were 46.8%, 44.6%, 44.3%, and 16.2%
for rs6433993, rs409238, rs288324 and rs4666865,
respectively (Table 3). All of the SNPs were in HWE (P >
0.05). Based on D' values (D' = 0.96), we identified one
block with high LD, ranging from intron 1 to intron 2,
which included rs6433993 and rs409238 (Figure 1).
When the haplotypes were reconstructed by rs6433993
and rs409238, all four possible haplotypes were obtained,
with a frequency of 46.2% for the commonest one. Since
the least common haplotype had a frequency of only
0.5%, we did not use it for subsequent statistical analysis
(Figure 1)
Association between SNPs and haplotypes with peak BMD
The results of the association of FRZB genotypes with peak
BMD by QTDT are summarized in Tables 4 and 5. There
were 349, 356, 350, and 218 informative female-offspring
nuclear families and 303, 315, 313, and 192 male-off-
spring nuclear families for the TDT analysis at rs6433993,
rs409238, rs288324, and rs4666865, respectively. No
population stratifications for single SNPs or haplotypes in
either female-offspring or male-offspring nuclear families
were found. In the total 401 female-offspring nuclear fam-
ilies, no single SNP showed significant evidence of associ-
ation (including within-family association and total
association) with peak BMD in the lumbar spine or hip.
As for male-offspring nuclear families, we failed to detect
significant within-family association between any single
SNP and BMD, although a total association was found
between rs4666865 and BMD in the spine (P = 0.0299).
Furthermore, no significant association was found
between haplotypes and BMD in the spine or hip in either
female- or male-offspring nuclear families (data not
shown). In multiple-parameter tests of 1,000 permuta-
tions, the permutations agreed with these within-family
association results (P > 0.05). In addition, using tests for
linkage and tests for linkage while modeling association,
no significant results for linkage between each SNP or
haplotype and BMD in the spine or hip were observed
(data not shown).
Discussion
To the best of our knowledge, this is the first study to test
the possible influence of the FRZB gene on peak BMD var-
iation in the Chinese population. After adjusting for the
covariates of age, height, and weight, we failed to find a
significant within-family association of any SNP or haplo-
type with peak BMD variation at the spine or the hip in
females or males.
In this study, we performed QTDT to test the relationship
between FRZB SNPs and haplotypes and BMD. Although
QTDT has a lower power to detect allelic association than
the population-based association approach, it is robust to
population stratification, which avoids the false-positive
or false-negative results that may easily occur in associa-
tion analyses because of an admixed and stratified popu-
lation. In our previous studies, the number of female-
offspring nuclear families offered more than 80% power
to test a candidate gene as a quantitative trait locus (QTL),
explaining about 10% of BMD variation [23,24,30]. Fur-
thermore, previously our method was successful in identi-
Linkage disequilibrium (LD) patterns and haplotype frequen- cies for the FRZB gene Figure 1
Linkage disequilibrium (LD) patterns and haplotype 
frequencies for the FRZB gene. Block structures depicted 
by Haploview. The increasing degree of darkness of the cells 
from white to black represents the increasing strength of LD. 
The values in the cells are the pair-wise degrees of LD indi-
cated by D' × 100 when D' < 1. In the figure, 1 to 4 represent 
rs6433993 rs409238 rs288324 and rs4666865 respectively. 
The haplotype frequency is denoted beside each correspond-
ing haplotype and calculated from unrelated parents (n = 
1602). a LD pattern for the FRZB gene. b Haplotype frequen-
cies for the FRZB gene.BMC Medical Genetics 2010, 11:1 http://www.biomedcentral.com/1471-2350/11/1
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fying genetic variation associated to BMD [23,24]. Based
on the power calculation, the present study had sufficient
power to detect any association between a SNP and peak
BMD in males and females. Moreover, the MAF of three of
the four SNPs was > 44%, and the heterozygosity was high
in our population, except for rs4666865, which may be
explained by the lower MAF of 16.2%. With greater heter-
ozygosity, more information can be derived from families
in the QTDT analysis. Although males and females may
share a genetic contribution to BMD, many candidate
genes have been observed to have different effects on
BMD in males and females [31-33]. In this study, we
found that heritability for peak BMD was similar in males
and in females; however, we separately analyzed the asso-
ciation between FRZB genotypes and peak BMD in males
and females, which might avoid the impact of gender mix-
ture on results. Because of the advantages mentioned
above, the possibility of false-negative findings in our
study was minimized.
Over the past few years, the canonical Wnt pathway has
been shown to play a substantial role in the regulation of
skeletal development [34] and to affect osteoblast differ-
entiation [35]. In this pathway, Wnt interacts with the friz-
zled/LRP5 or 6 coreceptor complex, which leads to the
stabilization of beta-catenin and its accumulation in the
nucleus, where it coactivates TCF/Lef transcription factors
[14]. A loss or gain of function in the Wnt coreceptor LRP5
is associated with osteoporosis or high bone mass, respec-
tively [36-39]. One family member of the frizzled gene
Table 5: P values of QTDT analyses for FRZB gene and BMD in male-offspring nuclear families
rs6433993 rs409238 rs288324 rs4666865
Tests of population stratification
Lumbar spine BMD 0.5236 0.7656 0.6731 0.8238
Total hip BMD 0.7361 0.6912 0.9392 0.8309
Femoral neck BMD 0.8698 0.7332 0.8995 1.0000
Test of total association
Lumbar spine BMD 0.5978 0.2937 0.2672 0.0299
Total hip BMD 0.5233 0.6343 0.7110 0.1164
Femoral neck BMD 0.8093 0.8872 0.7740 0.2963
Test of within-family association
Lumbar spine BMD 0.4155 0.4277 0.3610 0.3712
Total hip BMD 0.9793 0.9271 0.8014 0.5332
Femoral neck BMD 0.9752 0.7143 0.8034 0.6109
p 1000 permutations of within-family association
Lumbar spine BMD 0.3860 0.3700 0.3680 0.2780
Total hip BMD 0.9740 0.7350 0.8280 0.6520
Femoral neck BMD 0.9800 0.9290 0.8310 0.5290
BMD values are adjusted for age, height and weight. Bold indicates significant p values (p < 0.05)
Table 4: P values of QTDT analyses for FRZB gene and BMD in female-offspring nuclear families
rs6433993 rs409238 rs288324 rs4666865
Tests of population stratification
Lumbar spine BMD 0.2597 0.7082 0.7210 0.6797
Total hip BMD 0.1201 0.4474 0.6278 0.3498
Femoral neck BMD 0.9553 0.5299 0.8853 0.5387
Test of total association
Lumbar spine BMD 0.5910 0.9239 0.8353 0.3077
Total hip BMD 0.7237 0.6503 0.2945 0.7763
Femoral neck BMD 0.4555 0.2779 0.1819 0.9844
Test of within-family association
Lumbar spine BMD 0.5047 0.7121 0.8470 0.8338
Total hip BMD 0.1345 0.3765 0.3300 0.5350
Femoral neck BMD 0.6584 0.9779 0.5681 0.6117
p 1000 permutations of within-family association
Lumbar spine BMD 0.3950 0.6670 0.7830 0.8090
Total hip BMD 0.1110 0.3520 0.2680 0.5170
Femoral neck BMD 0.6440 0.9780 0.5990 0.6650
BMD values are adjusted for age, height, and weightBMC Medical Genetics 2010, 11:1 http://www.biomedcentral.com/1471-2350/11/1
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family, frizzled homolog 1, was also found to contribute
to the genetic regulation of bone mass and geometry [12].
FRZB inhibits Wnt signaling by either binding to Wnts
and preventing them from activating frizzled receptors or
directly inactivating the receptors [15]. Loughlin et al. [17]
found functional variants within FRZB gene were associ-
ated with hip osteoarthritis in females, possibly through a
reduced ability in antagonizing Wnt signaling. Since oste-
oarthritis and osteoporosis are shown to be inversely
related [40] and increased Wnt signaling is associated
with high bone mass [36-38], loss of function in FZRB
may lead to higher bone density. However, in this study,
we did not find an association between FRZB genotypes
and peak BMD in females or in males. These results dem-
onstrate that FRZB may not be required for the attainment
of peak BMD and suggest that other members of the sFRP
family may compensate for reduced FRZB activity [22].
Hsu et al. [41] performed a genome-wide scan for total
hip BMD from a large cohort in China that revealed a sig-
nificant QTL on chromosome 2q24.3 for total BMD (LOD
= 3.65). FRZB is a potential candidate gene in the chromo-
some 2q QTL region. However, in our study, we did not
observe any association between FRZB  polymorphisms
and peak BMD in the spine or hip. Other genes in this
region do contribute to the BMD variation, as our previ-
ous study has identified [24]. In addition, we focused on
the possible influence of the FRZB  genotypes on peak
BMD variation; whether the gene plays a more important
role in affecting bone loss requires further study.
Our study had several limitations. First, because we
selected the most informative SNPs with high MAF and r2,
some causal variants might be missed. We also did not
select the SNPs rs288326 (Arg200Trp) and rs7775
(Arg324Gly), which have been analyzed in other studies
[17,42,43], due to their MAFs of only 0 and 0.011, respec-
tively, and hence their poor informativeness in the Chi-
nese population. Second, although we had two relatively
large samples of nuclear families, the number of families
that had more than one child was small, making the
power to detect linkage between SNPs and BMD modest.
Conclusions
In summary, we tested the association and linkage
between SNPs and haplotypes in the FRZB gene with peak
BMD variation in the spines and hips of individuals in
Chinese nuclear families. Our results failed to support the
hypothesis that FRZB is a QTL associated with peak BMD
variation in the spines and hips of either the female or
male Chinese populations. Because ethnic difference in
FRZB genotypes may exist, other studies in different pop-
ulation are required to confirm these results.
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